Pentraxin-3 Levels Relate to the Wells Score and Prognosis in Patients with Acute Pulmonary Embolism
Open Access
- 12 March 2019
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2019, 1-6
Abstract
Objective. To investigate the value of the PTX-3 test in evaluating the prognosis of acute pulmonary embolism (APE). Method. 117 APE patients were selected and divided into two groups according to plasma PTX-3 levels, including the group in which () and the group in which (). Patients were stratified into high-risk, medium-risk, and low-risk groups according to the Wells scores, and the PTX-3 levels were compared among the groups. Patients had been followed-up as well. Results. According to the Wells scores, 11 patients were classified as high-risk (9.4%) and 68 were medium-risk (58.1%), while 38 were low-risk (32.5%). The PTX-3 levels in different risk groups were statistically different (all ). During the follow-up period, 6 deaths occurred in the group with elevated PTX-3 (≥3.0 ng/mL), while 2 deaths occurred in the group with nonelevated PTX-3 (<3.0 ng/mL). The difference between the two groups was statistically significant (). 13 patients were hospitalized due to recurrent pulmonary embolism, of which 12 were in the group with elevated PTX-3 (≥3.0 ng/mL), while 1 patient was in the group with nonelevated PTX-3 (<3.0 ng/mL). The difference was statistically significant (). Conclusion. The plasma PTX-3 level in APE patients is correlated with PE risk stratification. There is a significant correlation between PTX-3 levels and PE-related cardiac deaths, as well as the prognosis of recurrent PE. PTX-3 can be used as a clinical indicator of PE prognosis.
Keywords
Funding Information
- Tongji University (2016KJ052)
This publication has 34 references indexed in Scilit:
- Human Pentraxin 3 (PTX3) as a Novel Biomarker for the Diagnosis of Pulmonary Arterial HypertensionPLOS ONE, 2012
- Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statinCoronary Artery Disease, 2012
- Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory ResponseMediators of Inflammation, 2012
- Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerabilityJournal of Cardiology, 2011
- Comparison of the Wells and Revised Geneva Scores for the diagnosis of pulmonary embolism: an Australian experienceInternal Medicine Journal, 2011
- The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertilityJournal of Reproductive Immunology, 2009
- Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolismJournal of Thrombosis and Haemostasis, 2007
- Pentraxins in Innate Immunity: From C-Reactive Protein to the Long Pentraxin PTX3Journal of Clinical Immunology, 2007
- Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial InfarctionCirculation, 2004
- EpidemiologyChest, 1995